News: March 2013

MARCH 2013

Dialog to present at 35th Charing Cross Symposium on 7th April 2013

For 35 years the Charing Cross (CX) Symposium has attracted thousands of vascular specialists to London. In 2013, CX 35 aims to continue this tradition with an update on the latest vascular and endovascular controversies to arise over the past few years. The CX symposium has garnered a loyal following of nearly 1200 vascular surgeons and in the last six years has attracted over 600 interventional radiologists and interventional cardiologists.

Dr Linda Summerton, Director of Dialog Devices will be showcasing Dialog's innovative device for evaluation of peripheral arterial disease and exploring commercial opportunities for this exciting technology.

Dialog to present at 35th Charing Cross Symposium on 7th April 2013

MARCH 2013

Dialog to present at IN³ Medical Device 360° Dublin between 16-18 April 2013

Building on the success of past IN³ events in London, Paris, Rome, Brussels, and across the U.S., IN³ Medical Device 360° Dublin will bring together development- to commercial-stage device start-ups from around the world seeking funding or strategic partnership with top-tier venture capital and strategic decision makers.

Dialog Devices will be showcasing Dialog's innovative device for evaluation of peripheral arterial disease and exploring commercial opportunities for this exciting technology.

Dialog to present at IN³ Medical Device 360° Dublin between 16-18 April 2013

MARCH 2013

Dialog to present at BioTrinity 2013 between 14-16 May 2013

BioTrinity is the premier European Biopartnering and Investment Conference, partnering R&D companies with big Pharma and more biomedical investors than any other European partnering conference. 

Dialog Devices will be showcasing Dialog's innovative device for evaluation of peripheral arterial disease and exploring commercial opportunities for this exciting technology.

Dialog to present at BioTrinity 2013 between 14-16 May 2013

MARCH 2013

Patent awarded in Canada

Dialog Devices on 12th March 2013 have been granted patent no. 2552924 for Padd™ a system or method for assessing a subject’s peripheral blood circulation.